Fecal Microbiota Transplantation in Patients With Multiple Drug Resistant Klebsiella Pneumoniae Pneumonia
Key facts
- Who runs it
- luxia Kong
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 3 Dec 2024
- Planned end
- 30 Sept 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Fecal Microbiota Transplantation
- Record updated
- 3 December 2024
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (16)Hide the full registry criteria
Who can take part
- Age 18-75
- Meet the diagnostic criteria for community-acquired pneumonia or hospital-acquired pneumonia
- The etiological results of sputum or alveolar lavage fluid suggested MDR-KP infection
- The patient or his family members voluntarily participated, collected alveolar lavage fluid and stool samples, agreed to perform FMT treatment, and signed the informed consent
Who cannot take part
- Those who have recently been treated with high-risk immunosuppressive/cytotoxic drugs, such as rituximab, doxorubicin, or steroid hormones (20mg/d ponisone or higher) for more than 4 weeks
- Patients with severe damage of intestinal barrier such as sepsis and digestive tract perforation due to various reasons
- Those currently diagnosed with explosive colitis or toxic megacolon have gastroesophageal reflux disease or peptic ulcer; Subjects taking probiotics within 6 months
- Enteral nutrition patients who could not tolerate 50% of heat calorie requirements due to severe diarrhea, significant fibrous intestinal stenosis, severe gastrointestinal bleeding, high-flow intestinal fistula and other reasons
- Patients with obvious bleeding tendency, severe pulmonary hypertension, superior vena cava obstruction, and aortic aneurysm rupture risk
- Patients with malignant hypertension, recent myocardial infarction (≤6 months), severe arrhythmia, and cardiac insufficiency
- suffering from malignant tumor diseases, congenital or acquired immune deficiency diseases, other systemic inflammatory response diseases
- There is a mental disability or active mental illness that prevents informed consent
- Conditions deemed unsuitable for study inclusion by other clinicians
- Severe immunosuppression: adult neutrophils <1 500/mm3, child neutrophils <1 000/mm3
- Subjects with persistent bronchial asthma, severe pulmonary dysfunction, or inability to tolerate bronchoscopy
- Pregnancy or lactation
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Klebsiella pneumoniae pneumonia
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Multidrug-resistant Klebsiella pneumoniae (MDR-KP) infections account for 10% of all nosocomial infections, and even with effective antibiotics, the mortality rate is as high as 50%. Intestinal bacteria transplantation can not only treat intestinal diseases, but also inhibit the colonization and proliferation of drug-resistant bacteria. This study explored the therapeutic value of fecal microbiota transplantation in patients with MDR-KP pneumonia.
The 2 groups in the trial
- experimental groupTreatment being tested
This group of patients received conventional antibiotic therapy and fecal microbiota transplantation.
Treatment: Fecal Microbiota Transplantation
- control groupNo study treatment, for comparison
Patients in this group were treated with conventional antibiotics.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06641778, who can take part
- Record updated
- 3 December 2024